Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

Comparative OS of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− mBC in the US real-world setting

aromatase inhibitor